Free Trial

Hotchkis & Wiley Capital Management LLC Acquires New Position in Astrana Health, Inc. $ASTH

Astrana Health logo with Medical background

Key Points

  • Hotchkis & Wiley Capital Management LLC acquired 179,420 shares of Astrana Health, valued at approximately $5.56 million, constituting about 0.32% of the company's total shares.
  • Astrana Health reported a miss on earnings per share for the last quarter, with $0.19 compared to the consensus estimate of $0.36, despite achieving revenues of $654.81 million, exceeding expectations of $639.13 million.
  • As of now, 52.77% of Astrana Health's stock is held by institutional investors and hedge funds, indicating strong interest from the investment community.
  • MarketBeat previews the top five stocks to own by October 1st.

Hotchkis & Wiley Capital Management LLC purchased a new position in shares of Astrana Health, Inc. (NASDAQ:ASTH - Free Report) during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 179,420 shares of the company's stock, valued at approximately $5,564,000. Hotchkis & Wiley Capital Management LLC owned about 0.32% of Astrana Health at the end of the most recent quarter.

Several other hedge funds and other institutional investors also recently made changes to their positions in the company. Wells Fargo & Company MN boosted its holdings in Astrana Health by 41.5% in the fourth quarter. Wells Fargo & Company MN now owns 22,484 shares of the company's stock valued at $709,000 after acquiring an additional 6,596 shares during the last quarter. Envestnet Asset Management Inc. boosted its holdings in Astrana Health by 19.9% in the fourth quarter. Envestnet Asset Management Inc. now owns 7,124 shares of the company's stock valued at $225,000 after acquiring an additional 1,184 shares during the last quarter. Barclays PLC boosted its holdings in Astrana Health by 3.4% in the fourth quarter. Barclays PLC now owns 79,543 shares of the company's stock valued at $2,507,000 after acquiring an additional 2,627 shares during the last quarter. First Trust Advisors LP boosted its holdings in Astrana Health by 702.6% in the fourth quarter. First Trust Advisors LP now owns 107,343 shares of the company's stock valued at $3,385,000 after acquiring an additional 93,969 shares during the last quarter. Finally, Dimensional Fund Advisors LP boosted its holdings in Astrana Health by 10.7% in the fourth quarter. Dimensional Fund Advisors LP now owns 1,045,540 shares of the company's stock valued at $32,968,000 after acquiring an additional 101,192 shares during the last quarter. 52.77% of the stock is currently owned by institutional investors.

Astrana Health Trading Up 2.0%

Shares of Astrana Health stock traded up $0.63 on Friday, reaching $31.96. 358,021 shares of the company's stock were exchanged, compared to its average volume of 487,013. The company has a debt-to-equity ratio of 0.52, a quick ratio of 1.59 and a current ratio of 1.59. Astrana Health, Inc. has a 52 week low of $21.20 and a 52 week high of $63.20. The firm's 50-day moving average is $25.91 and its two-hundred day moving average is $28.34. The company has a market capitalization of $1.79 billion, a P/E ratio of 62.67, a price-to-earnings-growth ratio of 0.79 and a beta of 0.84.

Astrana Health (NASDAQ:ASTH - Get Free Report) last issued its earnings results on Thursday, August 7th. The company reported $0.19 earnings per share for the quarter, missing analysts' consensus estimates of $0.36 by ($0.17). The firm had revenue of $654.81 million for the quarter, compared to analyst estimates of $639.13 million. Astrana Health had a return on equity of 3.43% and a net margin of 1.04%.Astrana Health's revenue for the quarter was up 34.7% compared to the same quarter last year. During the same period in the previous year, the company earned $0.40 earnings per share. Astrana Health has set its Q3 2025 guidance at EPS. Sell-side analysts predict that Astrana Health, Inc. will post 1.15 EPS for the current fiscal year.

Astrana Health Company Profile

(Free Report)

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.

See Also

Institutional Ownership by Quarter for Astrana Health (NASDAQ:ASTH)

Should You Invest $1,000 in Astrana Health Right Now?

Before you consider Astrana Health, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Astrana Health wasn't on the list.

While Astrana Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

5 Hot Stocks to Buy Now: September’s Top Picks With Major Momentum
$15 Billion for Cybersecurity: The Government’s Next Big Push
Tesla’s Future Unleashed: Elon’s Robotics Move Changes Everything

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines